← Back to directory

Andrew K. Godwin

Researcher Next ID · RN-033311

Researcher · Biochemistry, Genetics and Molecular Biology

University of Kansas

Lawrence, Australia

Accepting doctoral researchersFunding unknown
Works count
991
Citation count
45,755
H-index
113
i10-index
412

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
BRCA gene mutations in cancer
Ovarian cancer diagnosis and treatment
Breast Cancer Treatment Studies
Gastrointestinal Tumor Research and Treatment
Cancer Genomics and Diagnostics

Publications

  • Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

    Cell · 2020 · https://doi.org/10.1016/j.cell.2020.06.013

  • Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

    Nature Genetics · 2020 · https://doi.org/10.1038/s41588-020-0609-2

  • Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip

    Nature Biomedical Engineering · 2019 · 10.1038/s41551-019-0356-9

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    Cell Reports · 2018 · 10.1016/j.celrep.2018.03.075

  • Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

    Cell · 2018 · 10.1016/j.cell.2018.03.034

  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

    Cancer Cell · 2018 · 10.1016/j.ccell.2018.03.014

  • The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

    Cell Reports · 2018 · 10.1016/j.celrep.2018.06.032

  • A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

    Cancer Cell · 2017 · 10.1016/j.ccell.2017.04.013

  • Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

    Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2016.69.4935

  • Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

    Cell Reports · 2016 · 10.1016/j.celrep.2016.02.024

  • The Molecular Taxonomy of Primary Prostate Cancer

    Cell · 2015 · 10.1016/j.cell.2015.10.025

  • Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics · 2015 · https://doi.org/10.1038/ng.3185

  • Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    JAMA · 2015 · https://doi.org/10.1001/jama.2014.5985

  • Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2014.57.1414

  • DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    PLoS Genetics · 2014 · https://doi.org/10.1371/journal.pgen.1004256

  • Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology

    Lab on a Chip · 2014 · 10.1039/c4lc00662c

  • Genome-wide association studies identify four ER negative–specific breast cancer risk loci

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2561

  • Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003212

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    Cancer Epidemiology Biomarkers & Prevention · 2012 · https://doi.org/10.1158/1055-9965.epi-11-0775

  • Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes

    Nature Genetics · 2012 · 10.1038/ng.2455

  • Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

    Breast Cancer Research · 2011 · https://doi.org/10.1186/bcr3052

  • A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

    Nature Genetics · 2011 · https://doi.org/10.1038/ng.985

  • Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

    PLoS Biology · 2011 · https://doi.org/10.1371/journal.pbio.1001199

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Cancer Research · 2010 · https://doi.org/10.1158/0008-5472.can-10-1907

  • A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.668

  • Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group

    Journal of Proteome Research · 2008 · 10.1021/pr800545q

  • Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

    The American Journal of Human Genetics · 2008 · https://doi.org/10.1016/j.ajhg.2008.02.008

  • Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.10.5437

  • MicroRNA-34b and MicroRNA-34c Are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-Independent Growth

    Cancer Research · 2007 · 10.1158/0008-5472.can-07-1585

  • RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Results from a Combined Analysis of 19 Studies

    The American Journal of Human Genetics · 2007 · https://doi.org/10.1086/522611

  • AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth

    Oncogene · 2004 · 10.1038/sj.onc.1207721

  • A Grb2-associated docking protein in EGF- and insulin-receptor signalling

    Nature · 1996 · 10.1038/379560a0

  • Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.

    PubMed · 1995

  • AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

    Proceedings of the National Academy of Sciences · 1992 · 10.1073/pnas.89.19.9267

  • High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

    Proceedings of the National Academy of Sciences · 1992 · 10.1073/pnas.89.7.3070

Current projects

    No projects listed.